8-K ·Filed Jun 18, 2026

OMER

OMEROS CORP
BULLISH
Impact 5/10
Horizonweeks Processed3mo ago SEC0001437749-26-021040
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

The debt repurchase reduces leverage and interest burden, a credit-positive signal for the convertible noteholders and common equity. Monitor for any subsequent equity issuance or cash burn updates in the next 10-Q. The averaging period based on common stock trading price introduces some uncertainty on final cost.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
OMER ▲ +69.84% at T+60d
LONG call ✓ call won +69.84% · α vs SPY +67.95% · entry $10.28 → $17.46
Entry anchored
Jun 18, 05:42 AM ET
via exchange tick
T+1d
+0.49%
call +0.49% · α +0.80%
$10.33
settled 3mo ago
T+5d
+4.28%
call +4.28% · α +5.95%
$10.72
settled 3mo ago
T+20d
-10.31%
call -10.31% · α -10.84%
$9.22
settled 2mo ago
T+60d
+69.84%
call +69.84% · α +67.95%
$17.46
settled 17d ago

Price Chart

Loading chart...

Executive Summary

Omeros Corporation repurchased up to $16.0 million aggregate principal amount of its 9.50% Convertible Senior Notes due 2029 for a total purchase price of up to approximately $34.0 million (including accrued interest and other obligations). The repurchase reduces outstanding convertible debt from ~$70.8 million to ~$54.8 million, lowering leverage and interest expense. The transaction is credit-positive for the preferred/convertible noteholders, reducing debt overhang and improving the equity cushion.

Key Facts

  • Omeros agreed to repurchase up to $16.0 million aggregate principal amount of its 9.50% Convertible Senior Notes due 2029
  • Total purchase price up to approximately $34.0 million, including accrued and unpaid interest
  • Repurchases expected to close between July 6, 2026 and July 16, 2026
  • Approximately $54.8 million aggregate principal amount of Notes will remain outstanding after the repurchase
  • Repurchase reduces outstanding debt from ~$70.8 million to ~$54.8 million

Financial Impact

Debt reduction of ~$16M principal (22.6% of outstanding notes) at a premium of ~$18M over par, funded by the company

debtleverageinterest expense

Risk Factors

  • The repurchase premium ($34M for $16M principal) is significant, indicating the notes were trading well above par
  • Remaining $54.8M in notes still outstanding; future conversion/dilution risk persists
  • Cash used for repurchase reduces liquidity for operations

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-021040
Document: 0001437749-26-021040-index-headers.html0001437749-26-021040
Document: 0001437749-26-021040-index.html0001437749-26-021040
Document: 0001437749-26-021040.txt0001437749-26-021040
10 reports for OMER
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OMER — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$18.75 $19.04▲ +1.55%▲ +1.44%$18.30 (−2.40%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 5/10
$18.61 $19.43▲ +4.41%▲ +4.15%$18.30 (−1.67%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.22 $20.13▲ +10.48%▲ +10.26%$18.30 (+0.44%)
Aug 21, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$19.32 $21.05▲ +8.95%▲ +7.64%$18.30 (−5.28%)
Jul 20, 2026
10w ago
8-K
BULLISH ★ 5/10
$9.53 $17.19▲ +80.38%▲ +77.82%$18.30 (+92.03%)
Jul 6, 2026
12w ago
8-K
NEUTRAL ★ 4/10
$10.34 $11.84▲ +14.51%▲ +15.07%$18.30 (+76.98%)
Jun 18, 2026
15w ago
8-K
BULLISH ★ 5/10
$10.28 $9.22▼ −10.31%▼ −10.84%$18.30 (+78.02%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 4/10
$10.18 $10.27▲ +0.88%▼ −1.01%$18.30 (+79.76%)
May 13, 2026
20w ago
8-K
MIXED ★ 6/10
$13.28 $8.74▼ −34.19%▼ −33.33%$18.30 (+37.80%)
Mar 31, 2026
26w ago
8-K
BULLISH ★ 9/10
$12.08 $14.56▲ +20.53%▲ +10.81%$18.30 (+51.49%)
Showing 10 of 10

US Market Status

Market Open — Closes in 2h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access